Composite Government Tracker Insider Trading Hedge Funds Red Flags Financials

Financials

RGEN

REPLIGEN CORP · Biological Products, (No Diagnostic Substances)

Financials Score

★★★★★

Metrics Available10 / 10

You vs. Peer Average

Gross Margin

RGEN

-149.2%

Peers

67.2%

Operating Margin

RGEN

39.1%

Peers

23.2%

Net Margin

RGEN

34.6%

Peers

14.9%

Revenue Growth (YoY)

RGEN

35.1%

Peers

2.2%

Earnings Growth (YoY)

RGEN

291.6%

Peers

20.8%

Return on Equity

RGEN

2.3%

Peers

3.5%

Return on Assets

RGEN

1.7%

Peers

4.4%

Debt / Equity

RGEN

0.26x

Peers

0.72x

Current Ratio

RGEN

8.37x

Peers

3.39x

FCF Margin

RGEN

66.5%

Peers

21.9%